Internal Medicine, Rheumatology · Danville, PA
NPI
1720041676
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
100 N Academy Ave
Danville, PA, 17822
Phone (570) 271-6416
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
4,116 services
Medicare patients, 2024
2,028
Average age 74
Drug cost, 2024
$2.2M
1,620 prescriptions
Company payments, 2025
$457
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas P Olenginski was code 77080 (standard x-ray), 1,364 times for 1,364 patients. In total Thomas P Olenginski billed 4,116 services in 21 codes, and Medicare paid $80K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 77080 Standard X-ray | Facility | 1,364 | 1,364 | $8.89 | $12K |
| 77092 Standard X-ray | Facility | 806 | 806 | $6.72 | $5,419 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 461 | 409 | $12.15 | $5,600 |
| 99214 Office E&M - Established | Facility | 320 | 283 | $64.56 | $21K |
| 77080 Standard X-ray | Office | 232 | 232 | $26.73 | $6,202 |
| 99213 Office E&M - Established | Facility | 207 | 192 | $49.63 | $10K |
| 77089 Standard X-ray | Office | 101 | 101 | $22.26 | $2,248 |
| 99204 Office E&M - New | Facility | 61 | 61 | $86.79 | $5,294 |
| 99203 Office E&M - New | Facility | 39 | 39 | $62.07 | $2,421 |
| 99205 Office E&M - New | Facility | 27 | 27 | $121.62 | $3,284 |
| 99222 Hospital E&M - Initial | Facility | 18 | 18 | $95.32 | $1,716 |
| 99215 Office E&M - Established | Facility | 16 | 16 | $95.03 | $1,520 |
| 77092 Standard X-ray | Office | 11 | 11 | $6.22 | $68.4 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 11 | 11 | $11.35 | $125 |
By year: 2022 $79K for 2,413 services; 2023 $71K for 2,583 services; 2024 $80K for 4,116 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas P Olenginski prescribed most often to Medicare patients was Alendronate Sodium, with 208 prescriptions and refills. In total Thomas P Olenginski wrote 1,620 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alendronate Sodium Generic | 208 | 443 | 61 | $2,144 |
| Prednisone Generic | 176 | 385 | 55 | $2,249 |
| Methotrexate Methotrexate Sodium | 174 | 433 | 51 | $5,572 |
| Teriparatide Generic | 157 | 157 | 25 | $401K |
| Hydroxychloroquine Sulfate Generic | 153 | 388 | 42 | $7,266 |
| Allopurinol Generic | 107 | 275 | 28 | $2,948 |
| Forteo Teriparatide | 57 | 57 | Under 11 | $193K |
| Tymlos Abaloparatide | 47 | 47 | 12 | $125K |
| Humira Pen Adalimumab | 46 | 46 | Under 11 | $338K |
| Methylprednisolone Generic | 38 | 72 | 26 | $674 |
| Enbrel Etanercept | 37 | 37 | Under 11 | $263K |
| Raloxifene Hcl Generic | 35 | 102 | 11 | $2,908 |
| Enbrel Sureclick Etanercept | 31 | 31 | Under 11 | $228K |
| Orencia Abatacept | 20 | 20 | Under 11 | $110K |
| Colchicine Generic | 19 | 39 | Under 11 | $1,230 |
Brand drugs: 468 claims; generic drugs: 1,135 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas P Olenginski $457 ($457 in general payments such as food, travel and fees) from 3 companies. The largest payer was Amgen Inc. with $235.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.